Jacobson Pharma Corporation Limited (2633.HK)

HKD 1.28

(2.4%)

Operating Income Summary of Jacobson Pharma Corporation Limited

  • Jacobson Pharma Corporation Limited's latest annual operating income in 2023 was 333.12 Million HKD , down -9.72% from previous year.
  • Jacobson Pharma Corporation Limited's latest quarterly operating income in 2023 FY was 288.09 Million HKD , down -9.72% from previous quarter.
  • Jacobson Pharma Corporation Limited reported an annual operating income of 319.1 Million HKD in 2022, up 43.17% from previous year.
  • Jacobson Pharma Corporation Limited reported an annual operating income of 222.88 Million HKD in 2021, up 20.15% from previous year.
  • Jacobson Pharma Corporation Limited reported a quarterly operating income of 167.15 Million HKD for 2023 Q4, down 0.0% from previous quarter.
  • Jacobson Pharma Corporation Limited reported a quarterly operating income of 138.48 Million HKD for 2023 Q2, down 0.0% from previous quarter.

Annual Operating Income Chart of Jacobson Pharma Corporation Limited (2023 - 2013)

Historical Annual Operating Income of Jacobson Pharma Corporation Limited (2023 - 2013)

Year Operating Income Operating Income Growth
2023 333.12 Million HKD -9.72%
2022 319.1 Million HKD 43.17%
2021 222.88 Million HKD 20.15%
2020 185.5 Million HKD -37.21%
2019 295.43 Million HKD -12.87%
2018 339.06 Million HKD 21.05%
2017 280.1 Million HKD 10.2%
2016 254.18 Million HKD 29.72%
2015 195.95 Million HKD 41.14%
2014 138.84 Million HKD -37.72%
2013 222.91 Million HKD 0.0%

Peer Operating Income Comparison of Jacobson Pharma Corporation Limited

Name Operating Income Operating Income Difference
Pak Fah Yeow International Limited 143.01 Million HKD -132.936%
Grand Pharmaceutical Group Limited 2.66 Billion HKD 87.492%
Extrawell Pharmaceutical Holdings Limited -8.16 Million HKD 4181.426%
Wai Yuen Tong Medicine Holdings Limited 40.88 Million HKD -714.887%
Qianhai Health Holdings Limited -52.18 Million HKD 738.38%
Lee's Pharmaceutical Holdings Limited 36.04 Million HKD -824.272%
Essex Bio-Technology Limited 310.32 Million HKD -7.346%
Tongfang Kontafarma Holdings Limited - HKD -Infinity%
PuraPharm Corporation Limited -66.04 Million HKD 604.385%
SSY Group Limited 1.63 Billion HKD 79.674%
JBM (Healthcare) Limited 174.2 Million HKD -91.226%
China Resources Pharmaceutical Group Limited 12.14 Billion HKD 97.258%